Skip to main content
. 2024 Jul 11;16(7):e64338. doi: 10.7759/cureus.64338

Table 4. The acceptance of cosmetic surgery scale (ACSS) of the participants is presented in frequencies (n) and proportions (%).

Q1: It makes sense to have a minor CS rather than spend years feeling bad about the way you look. Q2: CS is a good thing because it can help people feel better about themselves. Q3: In the future, I could end up having some kind of CS. Q4: People who are very unhappy with their physical appearance should consider CS as one option. Q5: If CS can make someone happier with the way they look, then they should try it. Q6: If I could have a surgical procedure done for free, I would consider trying CS. Q7: I have sometimes thought about having CS. Q8: If I knew there would be no negative side effects or pain, I would like to try CS. Q9: I would seriously consider having CS if my partner thought it was a good idea. Q10: I would never have any kind of plastic surgery. Q11: I would think about having CS in order to keep looking young. Q12: If it would benefit my career, I would think about having plastic surgery. Q13: I would seriously consider having cosmetic surgery if I thought my partner would find me more attractive. Q14: CS can be a big benefit to people's self-image. Q15: If a simple CS procedure would make me more attractive to others, I would think about trying it.

Items Disagree a lot Disagree somewhat Disagree a little Neutral Agree a little Agree somewhat Agree a lot Agreement %  
Yes No
Q1 390 (28.5%) 172 (12.6%) 97 (7.1%) 308 (22.5%) 190 (13.9%) 116 (8.5%) 95 (6.9%) 29.3 48.2
Q2 219 (16%) 100 (7.3%) 80 (5.8%) 336 (24.6%) 291 (21.3%) 186 (13.6%) 156 (11.4%) 46.3 29.1
Q3 480 (35.1%) 109 (8%) 102 (7.5%) 249 (18.2%) 224 (16.4%) 122 (8.9%) 82 (6%) 31.3 50.6
Q4 373 (27.3%) 160 (11.7%) 140 (10.2%) 332 (24.3%) 200 (14.6%) 106 (7.7%) 57 (4.2%) 26.5 49.2
Q5 390 (28.5%) 128 (9.4%) 117 (8.6%) 287 (21%) 237 (17.3%) 113 (8.3%) 96 (7%) 32.6 46.5
Q6 527 (38.5%) 124 (9.1%) 109 (8%) 278 (16.8%) 159 (11.6%) 108 (7.9%) 111 (8.1%) 27.6 55.6
Q7 513 (37.5%) 115 (8.4%) 86 (6.3%) 208 (15.2%) 235 (17.2%) 117 (8.6%) 94 (6.9%) 32.7 52.2
Q8 475 (34.7%) 124 (9.1%) 80 (5.8%) 201 (14.7%) 207 (15.1%) 130 (9.5%) 151 (11%) 35.6 49.6
Q9 517 (37.8%) 123 (9%) 97 (7.1%) 273 (20%) 164 (12%) 85 (6.2%) 109 (8%) 26.2 53.9
Q10 172 (12.6%) 120 (8.8%) 136 (9.9%) 369 (27%) 95 (6.9%) 87 (6.4%) 389 (28.4%) 41.7 31.3
Q11 587 (42.9%) 113 (8.3%) 102 (7.5%) 238 (17.4%) 158 (11.5%) 97 (7.1%) 73 (5.3%) 23.9 58.7
Q12 489 (35.7%) 113 (8.3%) 94 (6.9%) 259 (18.9%) 203 (14.8%) 100 (7.3%) 110 (8%) 30.1 50.9
Q13 558 (40.8%) 115 (8.4%) 86 (6.3%) 242 (17.7%) 178 (13%) 96 (7%) 93 (6.8%) 26.8 55.5
Q14 252 (18.4%) 67 (4.9%) 68 (5%) 274 (20%) 315 (23%) 204 (14.9%) 188 (13.7%) 51.6 28.3  
Q15 519 (37.9%) 135 (9.9%) 99 (7.2%) 234 (17.1%) 185 (13.5%) 95 (6.9%) 101 (7.4%) 27.8 55  
Total   32.7 47.64